Your browser is not supported. Please upgrade to a modern browser in order to use all the features of the UKHC web application: Firefox | Chrome | Microsoft Edge
Skip to main content
close menu
close menu

Search UK HealthCare

Molecular Tumor Board

The Markey Cancer Center Molecular Tumor Board (MTB) is a statewide service available to physicians at UK HealthCare and regional affiliates.

The MTB provides a forum for expert clinicians, pathologists and scientists to discuss and analyze tumor genotypes and molecular abnormalities in order to recommend patient specific targeted therapies. 

The MTB is intended to supplement oncology tumor boards and includes a broad range of expert panel members.

Clinicians can order a genomic report and submit a case study to be presented for review by the MTB during their twice monthly meetings. For an overview of the MTB, download the referral flyer below.

Download our referral flyer (PDF, 295 KB

  • Meetings

    The Molecular Tumor Board (MTB) meets:

    • 12 p.m.
    • Every first and third Tuesday

    MTB meetings are currently held via Zoom. Please email either Abigail Anderson, PhD or Rebecca Carpenter for Zoom details to attend.

    Some MTB meetings will include a 15-minute informational update on Precision Medicine. See Schedule for Topics and Speakers.

    To schedule a case presentation, review the details in the Case Submission section. All cases must be submitted to MTB seven days prior to meeting date.

    MTB Meeting Schedule

    Molecular Tumor Board 2021

    Month

    Day / Tues

    Location

    January

    5

    Zoom

    January

    19

    Zoom

    February

    2

    Zoom

    February

    16

    Zoom

    March

    2

    Zoom

    March

    16

    Zoom

    April

    6

    Zoom

    April

    20

    Zoom

    May

    4

    Zoom

    May

    18

    Zoom

    June

    1

    Zoom

    June

    15

    Zoom

    July

    6

    Zoom

    July

    20

    Zoom

    August

    3

    Zoom

    August

    17

    Zoom

    September

    7

    Zoom

    September

    21

    Zoom

    October

    5

    Zoom

    October

    19

    Zoom

    November

    2

    Zoom

    November

    16

    Zoom

    December

    7

    Zoom

    December

    21

    Zoom

    Continuing Medical Education (CME)

    If clinicians or pharmacists want to obtain CE Credit for this meeting, they must attend the meeting in person or via teleconference, then enter the provided access code on the CE Central website. Any questions or concerns regarding CE Credit can be directed to the MTB Manager at mtb@uky.edu.  

    Policy on Disclosure

    It is the policy of the Markey Cancer Center that the faculty, authors, planners and other persons who may influence the content of this CME activity disclose all relevant financial relationships with commercial interests in order to allow CME staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussions of unlabeled/unapproved uses of drugs or devices during their presentation.

  • Case Submission

    Cases must be submitted at least seven days prior to the meeting date.

    Genomics reports from UK HealthCare or external sources (Foundation, MATCH, etc.) can be submitted.

    A patient's genomic report is required for case submission. Please see how to order a genomic report through UK HealthCare under Order a Genomic Report below. 

    If you already have a genomic report, fill out the case submission form online, or download the form here.

    The patient’s genomic report can be sent to MTB by email.

    When the case submission and genomic report are received, the MTB manager will schedule the case for presentation and invite the treating clinician to the meeting.

    Treatment recommendations will be discussed at the MTB meeting. Recommendation letters will be faxed and/or mailed or uploaded into the electronic health record per the preference of the submitting physician. Specify method of results reporting on the case submission form.

    Note: There is no cost to submit a case to the Markey Cancer Center Molecular Tumor Board.

  • Research

    The Molecular Tumor Board currently has two prospective clinical trials evaluating integration of Precision Medicine into cancer therapeutics.

    • Part 1:  A prospective observational cohort study evaluating outcomes of genomic testing in patients with poor prognosis cancer.
    • Part 2: A therapeutic phase 2 sub-study evaluating genomic testing in human cancer and outcomes of targeted therapies recommended by an institutional multidisciplinary molecular tumor board in patients with poor prognosis cancer.

    Researchers who are interested in using the data or specimen collected under these protocols must complete the data request form.

  • Contact Us

    Directors Site Leaders 

    Jill Kolesar, PharmD

    Professor, College of Pharmacy

    Department of Pharmacy Practice and Science

    Chandler Park, MD, FACP

    Research Medical Director at Hardin Memorial Hospital, Central Kentucky Region

    UK Markey Cancer Center Research Network

    Rachel Ware Miller, MD

    Associate Professor, Division of Gynecologic Oncology

    Department of Obstetrics and Gynecology

     
    Administrative Office  

    Abigail Anderson, PhD,
    MTB Project Manager
    aman239@uky.edu

    Rebecca Carpenter,
    Administrative Support Associate
    rebecca.carpenter@uky.edu